Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of molecular medicine

• Publication date

  2002-06-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00109-002-0345-3PMID 12226740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymphotactin.

  2020cited by this paper
• Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma

  2001cited by this paper
• Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-γ

  2000cited by this paper
• Phase I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma.

  2000cited by this paper
• The CC Chemokine CKβ-11/MIP-3β/ELC/Exodus 3 Mediates Tumor Rejection of Murine Breast Cancer Cells Through NK Cells1

  2000cited by this paper
• Hybrid cell vaccination for cancer immunotherapy.

  2000cited by this paper
• Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma

  2000cited by this paper
• Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.

  2000cited by this paper
• The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells.

  2000cited by this paper
• Granulocyte-macrophage colony-stimulating factor gene-modified vaccines for immunotherapy of cancer.

  1999cited by this paper
• Long‐term survival and complete cures of B16 melanoma–carrying animals after therapy with tumor‐targeted IL‐2 and SEA

  1999influential reference
• An activation-responsive element in single C motif-1/lymphotactin promoter is a site of constitutive and inducible DNA-protein interactions involving nuclear factor of activated T cell.

  1999cited by this paper
• Enhanced Therapeutic Efficacy of Tumor RNA-Pulsed Dendritic Cells after Genetic Modification with Lymphotactin

  1999cited by this paper
• Adenoviral Vectors Expressing Lymphotactin and Interleukin 2 or Lymphotactin and Interleukin 12 Synergize to Facilitate Tumor Regression in Murine Breast Cancer Models

  1999cited by this paper
• Gene therapy of cancer.

  1998cited by this paper
• Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A

  1998cited by this paper
• Cancer vaccines

  1998cited by this paper
• Perforin and IFN-gamma are involved in the antitumor effects of antibody-targeted superantigens.

  1998cited by this paper
• Gene Therapy of Cancer

  1998cited by this paper
• Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.

  1998cited by this paper
• Lymphotactin: a new class of chemokine.

  1997cited by this paper
• Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.

  1997cited by this paper
• Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo.

  1997cited by this paper
• A Candidate for Cancer Gene Therapy: MIP-lα Gene Transfer to an Adenocarcinoma Cell Line Reduced T\imorigenicity and Induced Protective Immunity in Immunocompetent Mice

  1996cited by this paper
• Antibody‐targeted superantigen therapy induces tumor‐infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma

  1996cited by this paper
• Structure and expression of two highly related genes encoding SCM‐1/human lymphotactin

  1996cited by this paper
• Cytokine gene therapy of cancer.

  1996cited by this paper
• Combined chemokine and cytokine gene transfer enhances antitumor immunity

  1996cited by this paper
• RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of Tumorigenicity In Vivo: Role of Immune Cell Subpopulations

  1996cited by this paper
• Migratory response of human natural killer cells to lymphotactin

  1996cited by this paper
• Immune response during tumor therapy with antibody‐superantigen fusion proteins

  1996cited by this paper
• Cancer vaccines in gene therapy.

  1996cited by this paper
• Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.

  1995cited by this paper
• Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines.

  1995cited by this paper
• Tumor‐reactive superantigens suppress tumor growth in humanized scid mice

  1995cited by this paper
• Molecular cloning and functional characterization of human lymphotactin.

  1995cited by this paper
• Immunotherapy of human colon cancer by antibody-targeted superantigens

  1995cited by this paper
• Signals and Receptors Involved in Recruitment of Inflammatory Cells (*)

  1995cited by this paper
• Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.

  1995cited by this paper
• Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity

  1994cited by this paper
• Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

  1994cited by this paper
• Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.

  1994cited by this paper
• Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.

  1994cited by this paper
• Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody.

  1993cited by this paper
• Superantigen‐induced cytokines suppress growth of human colon‐carcinoma cells

  1993cited by this paper
• Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.

  1993cited by this paper
• Cancer vaccines.

  1993cited by this paper
• Common Expression of Melanoma Tumor-Associated Antigens Recognized by Human Tumor Infiltrating Lymphocytes: Analysis by Human Lymphocyte Antigen Restriction

  1991cited by this paper
• CD4+ T cell clones specific for the human p97 melanoma-associated antigen can eradicate pulmonary metastases from a murine tumor expressing the p97 antigen.

  1991cited by this paper
• Production of TNF-alpha and TNF-beta by staphylococcal enterotoxin A activated human T cells.

  1990cited by this paper
• FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens

  1989cited by this paper
• The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.

  1989cited by this paper
• Lymphokine activation of T4+ T lymphocytes and monocytes.

  1987cited by this paper

• Suppression of the malignancy of mammary tumor in mice model by inactivated preparation of Mycobacterium obuense

  2021cites this paper
• Incidences of Mould and Bacterial Toxins in Dairy Products

  2017cites this paper
• Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism

  2011cites this paper
• Neutralizing endogenous chemokines with small molecules

  2010cites this paper
• Functional expression of the chemokine receptor XCR1 on oral epithelial cells

  2010cites this paper
• A quantitative real-time immuno-PCR approach for detection of staphylococcal enterotoxins

  2007cites this paper
• A novel anticancer approach: SEA-anchored tumor cells expressing heat shock protein 70 onto the surface elicit strong anticancer efficacy.

  2005cites this paper
• Preparation of murine B7.1‐glycosylphosphatidylinositol and transmembrane‐anchored staphylococcal enterotoxin

  2005cites this paper
• Anti-tumor responses induced by chemokine CCL19 transfected into an ovarian carcinoma model via fiber-mutant adenovirus vector.

  2005cites this paper
• Superantigen-SEA gene modified tumor vaccine for hepatocellular carcinoma: an in vitro study.

  2004cites this paper
• Epigenetic regulation of protein phosphatase 2A (PP2A), Lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells

  2004cites this paper
• Potent antitumor effect elicited by superantigen‐linked tumor cells transduced with heat shock protein 70 gene

  2004cites this paper